Association Between HIV-1 Tropism and CCR5 Human Haplotype E in a Caucasian Population

被引:4
|
作者
Huik, Kristi [1 ]
Avi, Radko [1 ]
Uibopuu, Helen [2 ]
Pauskar, Merit [1 ]
Margus, Tonu [3 ,4 ]
Karki, Tonis [1 ]
Krispin, Tonu [1 ]
Kool, Piret [5 ]
Rueuetel, Kristi [6 ]
Talu, Ave [7 ]
Abel-Ollo, Katri [6 ]
Uuskuela, Anneli [7 ]
Carrillo, Andrew [8 ,9 ,10 ]
He, Weijing [8 ,9 ,10 ]
Ahuja, Sunil K. [8 ,9 ,10 ]
Lutsar, Irja [1 ]
机构
[1] Univ Tartu, Fac Med, Dept Microbiol, EE-50411 Tartu, Estonia
[2] West Tallinn Hosp Labs, Tallinn, Estonia
[3] Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, EE-50411 Tartu, Estonia
[4] Estonian Bioctr, Tartu, Estonia
[5] Tartu Prison Hosp, Tartu, Estonia
[6] Natl Inst Hlth Dev, Tallinn, Estonia
[7] Univ Tartu, Fac Med, Dept Publ Hlth, EE-50411 Tartu, Estonia
[8] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[9] South Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA
[10] South Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA
基金
美国国家卫生研究院;
关键词
CCR5; X4 tropic viruses; intravenous drug users; TREATMENT-NAIVE PATIENTS; CELL-SURFACE CCR5; DISEASE PROGRESSION; PROMOTER POLYMORPHISM; VIRUSES; DENSITY; TRANSMISSION; PREVALENCE; EXPRESSION; EPIDEMIOLOGY;
D O I
10.1097/QAI.0000000000000127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:The influence of the diversity of CCR5 on HIV susceptibility and disease progression has been clearly demonstrated but how the variability of this gene influences the HIV tropism is poorly understood. We investigated whether CCR5 haplotypes are associated with HIV tropism in a Caucasian population.Methods:We evaluated 161 HIV-positive subjects in a cross-sectional study. CCR5 haplotypes were derived after genotyping 9 CCR2-CCR5 polymorphisms. The HIV subtype was determined by phylogenetic analysis using the maximum likelihood method and viral tropism by the genotypic tropism assay (geno2pheno). Associations between CCR5 haplotypes and viral tropism were determined using logistic regression analyses. Samples from 500 blood donors were used to evaluate the representativeness of HIV-positives in terms of CCR5 haplotype distribution.Results:The distribution of CCR5 haplotypes was similar in HIV-positive subjects and blood donors. The majority of viruses (93.8%) belonged to HIV-1 CRF06_cpx; 7.5% were X4, and the remaining were R5 tropic. X4 tropic viruses were over represented among people with CCR5 human haplotype E (HHE) compared with those without this haplotype (13.0% vs 1.4%; P = 0.006). People possessing CCR5 HHE had 11 times increased odds (odds ratio = 11.00; 95% confidence interval: 1.38 to 87.38) of having X4 tropic viruses than those with non-HHE. After adjusting for antiretroviral (ARV) therapy, neither the presence of HHE nor the use of ARV was associated with X4 tropic viruses.Conclusions:Our results suggest that CCR5 HHE and ARV treatment might be associated with the presence of HIV-1 X4 tropic viruses.
引用
收藏
页码:239 / 244
页数:6
相关论文
共 50 条
  • [1] A haplotype in the CCR5 gene promoter was associated with the susceptibility to HIV-1 infection in a northern Chinese population
    Xu, Lidan
    Qiao, Yuandong
    Zhang, Xuelong
    Sun, Haiming
    Wang, Jingwei
    Sun, Donglin
    Jia, Xueyuan
    Shen, Chao
    Zhao, Yanling
    Jin, Yan
    Yu, Yang
    Ling, Hong
    Wang, Kaili
    Fu, Songbin
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (01) : 327 - 332
  • [2] Hiv-1 tropism testing and clinical management of CCr5 antagonists: Quebec review and recommendations
    Tremblay, Cecile
    Hardy, Isabelle
    Lalonde, Richard
    Trottier, Benoit
    Tsarevsky, Irina
    Vezina, Louis-Philippe
    Roger, Michel
    Wainberg, Mark
    Baril, Jean-Guy
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (04) : 202 - 208
  • [3] Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection
    Li, Hui
    Liu, Ting-Jun
    Hong, Ze-Hui
    INFECTION GENETICS AND EVOLUTION, 2014, 24 : 99 - 104
  • [4] HIV-1 infection and CCR5Δ32 homozygosis
    Ballana, Ester
    Este, Jose A.
    FUTURE VIROLOGY, 2012, 7 (07) : 653 - 658
  • [5] CCR5 as target for HIV-1 gene therapy
    Nazari, Reza
    Joshi, Sadhna
    CURRENT GENE THERAPY, 2008, 8 (04) : 264 - 272
  • [6] Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
    Mohamed, Hager
    Gurrola, Theodore
    Berman, Rachel
    Collins, Mackenzie
    Sariyer, Ilker K.
    Nonnemacher, Michael R.
    Wigdahl, Brian
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [7] Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers
    Picton, Anabela C. P.
    Paximadis, Maria
    Koor, Gemma W.
    Bharuthram, Avani
    Shalekoff, Sharon
    Lassauniere, Ria
    Ive, Prudence
    Tiemessen, Caroline T.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] CCR5 antagonists: a therapeutic option in HIV-1 perinatally infected children experiencing virologic failure?
    Frange, Pierre
    Briand, Nelly
    Veber, Florence
    Moshous, Despina
    Avettand-Fenoel, Veronique
    Rouzioux, Christine
    Blanche, Stephane
    Chaix, Marie-Laure
    AIDS, 2012, 26 (13) : 1673 - 1677
  • [9] Relationship between CCR5(WT/Δ32) heterozygosity and HIV-1 reservoir size in adolescents and young adults with perinatally acquired HIV-1 infection
    Martinez-Bonet, M.
    Gonzalez-Serna, A.
    Clemente, M. I.
    Moron-Lopez, S.
    Diaz, L.
    Navarro, M.
    Puertas, M. C.
    Leal, M.
    Ruiz-Mateos, E.
    Martinez-Picado, J.
    Munoz-Fernandez, M. A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (05) : 318 - 324
  • [10] Genotyping of CCR5 Gene, CCR2b and SDF1 Variants Related to HIV-1 Infection in Gabonese Subjects
    Mombo, Landry Erik
    Bisseye, Cyrille
    Mickala, Patrick
    Ossari, Simon
    Makuwa, Maria
    INTERVIROLOGY, 2015, 58 (01) : 22 - 26